Codexis (CDXS) Amortizatization of Intangibles (2010 - 2026)
Codexis (CDXS) recorded quarterly Amortizatization of Intangibles of $935000.0 in Q1 2026, up 7.97% quarter-over-quarter from $866000.0 in Q4 2025, and up 30.95% on a YoY basis from $714000.0 in Q1 2025.
Codexis (CDXS) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Codexis' Amortizatization of Intangibles history runs 14 years deep, the most recent figure standing at $935000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 30.95% year-over-year to $935000.0; the TTM figure through Mar 2026 stood at $3.3 million (up 4.48% YoY), while the FY2025 annual figure was $3.0 million, down 4.4% from the prior year.
- Amortizatization of Intangibles was $935000.0 for Q1 2026 at Codexis, up from $866000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.3 million in Q2 2023 to a low of $714000.0 in Q1 2025.
- Historically, Amortizatization of Intangibles has averaged $965705.9 across 5 years, with a median of $866000.0 in 2025.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles soared 84.9% in 2022, then slumped 38.42% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at $1.2 million in 2022, then plunged by 38.42% to $758000.0 in 2023, then climbed by 8.18% to $820000.0 in 2024, then advanced by 5.61% to $866000.0 in 2025, then grew by 7.97% to $935000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $935000.0 (Q1 2026), $866000.0 (Q4 2025), and $738000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Codexis | 213.30 Mn | 148.16 Mn | 13.18 Mn | 935,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 935,000.00 |
| Mar 31, 2026 | 935,000.00 |
| Dec 31, 2025 | 866,000.00 |
| Dec 31, 2025 | 866,000.00 |
| Sep 30, 2025 | 738,000.00 |
| Sep 30, 2025 | 738,000.00 |
| Jun 30, 2025 | 726,000.00 |
| Jun 30, 2025 | 726,000.00 |
| Mar 31, 2025 | 714,000.00 |
| Mar 31, 2025 | 714,000.00 |
| Dec 31, 2024 | 820,000.00 |
| Dec 31, 2024 | 820,000.00 |
| Sep 30, 2024 | 803,000.00 |
| Sep 30, 2024 | 803,000.00 |
| Jun 30, 2024 | 788,000.00 |
| Jun 30, 2024 | 788,000.00 |
| Mar 31, 2024 | 773,000.00 |
| Mar 31, 2024 | 773,000.00 |
| Dec 31, 2023 | 758,000.00 |
| Dec 31, 2023 | 758,000.00 |